【摘要】 医药行业的特殊背景、实体规则的欠缺以及程序性框架的不完善,导致当前医药行业乱象频生,药品价格垄断问题尤为严重。原料药垄断、仿制药企与专利药企市场之争的深化,加之政府放开药品定价后的药价飙高,推动药品价格垄断进入反垄断执法"重灾区"。医改进入深水区的当下,亟需反垄断执法机构强势介入,深入剖析垄断成因、厘清垄断基本形式,同时完善规制药品价格垄断程序性框架、弥补实体规则不足,方能从根本上维系医药市场的稳健运行。更多还原

【Abstract】 For pharmaceutical industry,the lack of entity rules and the imperfect procedural framework have led to the current turmoil,especially the drug price monopoly. API monopoly,generics companies and patent drug firms made drug prices soared after the government deregulated drug pricing. The anti-monopoly enforcement authority needs A strong intervene in drug price monopoly and the procedural framework,which can make up for the lack of regulation rules and to maintain the stable operation of the medical market.更多还原